ACE inhibitory casein peptide lowers blood pressure and reshapes gut microbiota in a randomized double blind placebo controlled trial.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- ACE inhibitory casein peptide lowers blood pressure and reshapes gut microbiota in a randomized double blind placebo controlled trial.
- Published In:
- Scientific reports, 15(1), 13840 (2025)
- Authors:
- Li, Kexin, Jiang, Peng, Li, Shuangqi, Sun, Jin, Qi, Ce
- Database ID:
- RPEP-12077
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-12077APA
Li, Kexin; Jiang, Peng; Li, Shuangqi; Sun, Jin; Qi, Ce. (2025). ACE inhibitory casein peptide lowers blood pressure and reshapes gut microbiota in a randomized double blind placebo controlled trial.. Scientific reports, 15(1), 13840. https://doi.org/10.1038/s41598-025-98446-6
MLA
Li, Kexin, et al. "ACE inhibitory casein peptide lowers blood pressure and reshapes gut microbiota in a randomized double blind placebo controlled trial.." Scientific reports, 2025. https://doi.org/10.1038/s41598-025-98446-6
RethinkPeptides
RethinkPeptides Research Database. "ACE inhibitory casein peptide lowers blood pressure and resh..." RPEP-12077. Retrieved from https://rethinkpeptides.com/research/li-2025-ace-inhibitory-casein-peptide
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.